Loading...
Antithyroid drugs in Graves’ disease: Are we stretching it too far?
INTRODUCTION: Early and durable achievement of euthyroid or hypothyroid status with low likelihood of relapse is the key to effective treatment of Graves’ disease (GD). Although antithyroid drugs (ATDs) are commonly used first-line agents, likelihood of remission remains highest with radioactive iod...
Na minha lista:
| Udgivet i: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5040037/ https://ncbi.nlm.nih.gov/pubmed/27730067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.190525 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|